About Altasciences
From Our Stocking to Your Inbox: Happy Holidays!
'Tis the season for a little extra joy, and we're thrilled to present "Questions From a Stocking: Holiday Edition!" in which Altascientists fully embrace the holiday spirit as they answer rapid-fire questions pulled from our new favorite stocking.
As we share these lighthearted moments, we're filled with deep gratitude for the ideas, discoveries, trials, and successes you've shared with us this year. Your partnership has been invaluable, and we're honored to support your efforts in bringing life-saving therapeutics to our global community.
From our stocking to your inbox, we wish you and your loved ones a very happy holidays.
Watch "Questions From A Stocking: Holiday Edition"
Getting to the Heart of Science with Yosuke Izumi
The Stories That Inspire
Meet Yosuke Izumi, one of our Directors of Business Development at Altasciences. From Japan to L.A., his career demonstrates his adaptability, an attribute that he uses in his personal life as well as in surfing. Each day presents new challenges—whether it’s helping you find your drug development solutions or mastering the ocean on his surfboard. Even with the best planning, unexpected things may happen, but Yosuke relies on his philosophy of always being solutions-oriented and knowing how to ride the waves.
4 Essential Topics to Cover in Your First CRO Meeting
Top Life Science Resources for Fall 2024
There’s a lot of life science content out there, so for your convenience, we’ve curated a selection of expert insights, tips, case studies, and scientific and regulatory information. Catch up on what you might have missed below!
Your Definitive Life Science Resource Guide is Back!
Top 10 Life Science Resources
We’ve curated a selection of recently published expert insights, tips, case studies, and scientific and regulatory information, just for you.
1. Webinar: Innovative Surgical Solutions in Safety Assessment Studies
Explore the latest advancements in surgical techniques for your toxicology and safety pharmacology studies. This webinar dives into innovative methods and techniques for new dose routes and procedures that help move your compounds one step closer to approval. Watch it now.
2. White Paper: Whole Genome Sequencing, Proteomics, and Function Characterization of the Sinclair Nanopig™
Discover how the Sinclair Nanopig™ is transforming nonclinical safety assessments. This comprehensive white paper details the genome sequencing and functional characterization of the Sinclair Nanopig™, offering key insights for pharmaceutical and biopharmaceutical safety evaluations. Read now.
3. Video: The True Meaning of Moving in Unison
See how collaboration and precision ensure seamless clinical trial implementation. Experts from Altasciences provide their insights on the importance of synergy between clinical and bioanalytical teams, and how you will benefit from our integrated CRO solution. Watch the video.
4. Blog: Case Study: How to Evaluate Human Abuse Potential (HAP) for CNS Drugs
Explore how Altasciences evaluated the human abuse potential of mirogabalin, a CNS drug, by comparing it with diazepam and pregabalin in clinical trials. The study used a double-blind, crossover design with recreational drug users to evaluate subjective effects and likability. Read the case study.
5. The Altascientist: Issue 41—Immunomodulation Assessments for Clinical Trials: Sophisticated Bioanalytical Approaches to Support Complex Modalities
Uncover the complexities of immunomodulation in this issue of The Altascientist. This resource provides valuable insights into optimizing drug development while ensuring regulatory compliance and innovative solutions for immunotherapy. Read or listen now.
6. eBook: Key Considerations for Nonclinical AAV Gene Therapy Development
Explore the ins and outs of AAV gene therapy development. This eBook offers a detailed roadmap, from preclinical research through to bioanalytical testing and manufacturing, equipping you with the knowledge needed to smoothly navigate the complexities of gene therapy. Read now.
7. The Altascientist: Issue 40—Analytical Testing: Accurate and Complete Characterization of Your API
Discover how precise analytical testing ensures the proper absorption and therapeutic effect of your drug products. This issue of The Altascientist dives into methods for identifying and characterizing your API, common techniques to determine particle size distribution (PSD), and formulation approaches to maximize bioavailability. Read or listen here.
8. Infographic: Nanomilling—Enhancing Drug Solubility and Bioavailability
Learn how nanomilling, a cutting-edge manufacturing technique, can be used to tackle poor water solubility and bioavailability in drug development. This infographic provides an overview of how nanomilling works, offering a practical solution for improving the formulation of poorly soluble drugs. View the infographic.
9. Video: An Integrated CRO/CDMO
Discover how Altasciences breaks down organizational silos, streamlines project management, and provides effortless communication. In this video, leaders from across Altasciences come together to discuss how we safely accelerate your early-phase drug development journey using a seamless and integrated approach. Watch the video.
10. Fact Sheet: Clinical Trial Site Selection and Management
Learn how Altasciences can identify, select, and manage clinical trial sites to optimize patient enrollment, and ensure high data integrity throughout your study. Read the fact sheet.Recent Regulatory Updates:
- FDA Guidance Draft – Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
- FDA Final Guidance – Conducting Clinical Trials With Decentralized Elements
- FDA Final Guidance – Providing Regulatory Submissions in Electronic Format | Certain Human Pharmaceutical Product Applications and Related Submissions Using the eCTD Specifications Guidance for Industry
- FDA Final Guidance – ANDA Submissions | Amendments to Abbreviated New Drug Applications Under GDUFA
- EMA Guideline – Reflection Paper on Establishing Efficacy Based on Single-Arm Trials Submitted as Pivotal Evidence in a Marketing Authorization Application
Altasciences’ Chief Scientific Officer Named a PharmaVoice 100 Honoree
Greater Montréal, Québec, October 9, 2024 — Altasciences is proud to announce that Dr. Beatrice Setnik, PhD, has been honored as a PharmaVoice 100 winner. Dr. Setnik made the list of 100 honorees for her hands-on leadership and nearly 20 years of experience in clinical drug development, with a focus on abuse potential studies. In addition to her role as Chief Scientific Officer (CSO) at Altasciences, she serves as an adjunct professor at the University of Toronto and helps develop educational programs for children in her spare time.
PharmaVoice featured Dr. Setnik in an exclusive interview, highlighting her contributions to the life sciences field, and deeper insights into her visionary leadership and expertise. Selected from nominations by readers and colleagues, each honoree was evaluated by the PharmaVoice team and categorized into 10 distinct groups: Standout Leaders, Cancer Care Visionaries, Cardiometabolic All-Stars, Trailblazers, Biotech Pathfinders, Rare Disease Warriors, Tech and AI Wizards, Clinical Trial Pros, Patient Champions, and Cell and Gene Therapy Pioneers. Each winner represents the transformative impact of the pharmaceutical industry in their own unique way.
"Thank you very much to PharmaVoice for this honor, which would have been impossible without the support of my colleagues, the clients at Altasciences, and of course, my peers and collaborators over the years,” said Dr. Setnik. “To be included in a list of such incredible innovators and trailblazers is extremely humbling."
Dr. Setnik joined Altasciences as Chief Scientific Officer in 2019, working with her team to develop new clinical methods to safely study compounds in early-phase drug development, and adapting clinical methods to establish a safe, comfortable, stimulus-controlled environment for study participants. She has been previously recognized as a “Scientific Trailblazer” by Insights Care and was named one of the 30 Most Influential People in the Pharma Industry by The Medicine Maker in 2024.
“These honorees are inspirations. Their teams look to them for guidance, their patients for support, and their organizations for direction. Each winner represents progress toward a healthier future for everyone that is bolstered by science and technological advancements. We are excited to recognize their contributions through this annual list,” said Meagan Parrish, Lead Editor, PharmaVoice.
Since 2005, the PharmaVoice 100 has become one of the publication’s most anticipated features. From academia and nonprofits to Big Pharma, startups and tech companies, it is the only awards program in the industry that honors individuals from all sectors of life sciences. These honorees, from the clinic to the C-suite, are making meaningful contributions to their fields and striving to improve outcomes for patients around the world.
About Altasciences
Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster. To learn more about Altasciences, visit altasciences.com.
About PharmaVoice
PharmaVoice is a leading industry publication operated by Industry Dive. Our stories deliver the most important voices and ideas in the life sciences to industry leaders.
About Industry Dive
Industry Dive, an Informa business, is a leading business journalism company. Over 14 million decision-makers across 20+ competitive industries rely on our exclusive insight and analysis delivered through more than 30 publications.
Julie-Ann Cabana
Altasciences
+1 514 601-9763
jcabana@altasciences.com
Getting to the Heart of Science With Talita Conte, Scientific Project Manager
The Stories That Inspire
Meet Talita Conte, one of our dedicated scientific project managers. From São Paulo to Montréal, her journey is a testament to the power of passion and innovation in science. After making a breakthrough in myotonic dystrophy type 1 published in Nature Communications, she transitioned to project management at Altasciences, where she continues to drive fast-paced, impactful clinical trials.
Your Definitive Life Science Resource Guide
Top 10 Life Science Resources
We’ve curated a selection of recently published expert insights, tips, case studies, and scientific and regulatory information, just for you.
- Webinar:Best Practices to Reduce Animal Use in Toxicology Studies
Explore the advantages and limitations of various methods for minimizing the number of research animals used in your toxicology studies, while maintaining robust, high-quality, and reproduceable findings. Watch it now.
- The Altascientist: Issue No. 39 Key Considerations for Nonclinical Dermal Studies—Advancing to Phase I
Find out more about the nonclinical requirements for moving dermal studies into Phase I clinical trials, including formulation considerations, species selection, and ideal candidates for transdermal drug delivery systems. Read or listen now.
-
Enjoy this comprehensive review of well-known cognitive and pharmacodynamic test batteries, including their applications and limitations in first-in-human studies. Watch the webinar.
-
eBook: Regulatory Comparisons for Starting First-in-Human Clinical Trials
Delve into the different regulatory requirements, procedures, and timelines based on where you choose to conduct your studies—whether in Canada, the U.S., the UK, or the EU. Read the eBook.
-
Webinar: Nonclinical Adeno-Associated Virus (AAV) Gene Therapy Development
Explore pre-existing immunity challenges, vector targets, biodistribution, and the role of PCR analysis in assessing therapy efficacy and safety, including case studies highlighting the delicate balance between innovation and regulatory compliance. Watch now.
-
Poster: Sensitive Quantitation of Antisense Oligonucleotides (ASOs)
Hear about the complex workings of the novel finger-stick-derived capillary collection method, which has recently emerged as an alternative to traditional venipuncture. Watch the poster presentation.
-
Podcast: Successful Manufacturing of Clinical Trial Supply
Join our formulation and pharmacy experts as they share insider secrets for overcoming clinical trial challenges and resolving issues that could impact your drug development program's timeline. View the podcast.
-
The Altascientist: Issue No. 38 Ensuring Successful Formulation and Drug Product Manufacture for Preclinical Testing
Uncover the key factors in effective formulation development and manufacturing for safety assessments. Read or listen here.
-
Fact Sheet: Clinical Trial Site Selection and Management
Learn how we ensure on-time and on-budget completion of your clinical trial projects, and leverage our extensive data and experience to place your study where it makes the most sense, either at one of our clinical sites or at a partner site (or both). Read the fact sheet.
-
Video: Connecting the Dots—So You Don’t Have To
Discover a simpler drug development journey—one solution seamlessly connecting to the next. Watch the video.
Recent Regulatory Updates:
- FDA: Guidance Draft – Data Integrity for In Vivo Bioavailability and Bioequivalence Studies
- FDA: Guidance Revision – Controlled Correspondence Related to Generic Drug Development
- FDA: Final Guidance – Clinical Pharmacology Considerations for Antibody-Drug Conjugates
- FDA: Guidance Draft – Early Alzheimer’s Disease: Developing Drugs for Treatment
- FDA: Final Guidance – Human Gene Therapy Products Incorporating Human Genome Editing
A Message of Thanks From CEO Chris Perkin
On June 12, Altascientists at all nine of our facilities took time to celebrate each other and the important work that we do as your partners. Altasciences Day, as we like to call it, is a testament to our journey with you—a journey defined by collaboration, dedication, and moving in unison.
I want to extend my heartfelt gratitude for your ongoing trust and partnership, and for giving us the opportunity to help you bring better drugs to the people who need them, faster.
Here’s to many more remarkable accomplishments, and even more reasons to celebrate.
Cheers,
Chris Perkin
CEO, Altasciences
Simpler Clinical Development From Day Dot
Connecting the Dots With Comprehensive CRO Solutions
When you CONNECT THE DOTS, you open a world of possibilities.
At Altasciences, we connect the dots, so you don’t have to. With you in mind, we establish a clear and consistent path from drug discovery to delivery—one solution seamlessly connecting to the next. All you have to do is reach out and get the conversation started.
Ready for a simpler drug development journey? Contact us today.
You may also be interested in these resources:
- Webpage: Clinical Research Support Services
- Video: Clinical Trial Site Identification, Selection, and Management
- Fact Sheet: Integrated Research Support Services